Journal of International Oncology ›› 2024, Vol. 51 ›› Issue (8): 504-509.doi: 10.3760/cma.j.cn371439-20231130-00084
• Original Articles • Previous Articles Next Articles
Received:
2023-11-30
Revised:
2024-04-09
Online:
2024-08-08
Published:
2024-09-24
Contact:
Wang Yan,Email:h92dmr@163.com
Wang Yan. Differential diagnostic value of transvaginal ultrasound elastography combined with serum miR-144-3p,CMTM6 for cervical precancerous lesions and cervical cancer[J]. Journal of International Oncology, 2024, 51(8): 504-509.
[1] | Gautam H, Mehta S, Nayar N, et al. Prevalence of human papilloma virus and Chlamydia trachomatis in endometrial and cervical carcinoma: a comparative study in North Indian women[J]. Syst Biol Reprod Med, 2023, 69(6): 399-409. DOI: 10.1080/19396368.2023.2247517. |
[2] | Balasubramaniam SD, Balakrishnan V, Oon CE, et al. Key molecular events in cervical cancer development[J]. Medicina (Kaunas), 2019, 55(7): 384. DOI: 10.3390/medicina55070384. |
[3] | Du YY, Yan XJ, Guo YJ, et al. Transvaginal real-time shear wave elastography in the diagnosis of endometrial lesions[J]. Int J Gen Med, 2021, 14: 2849-2856. DOI: 10.2147/IJGM.S312292. |
[4] | He LL, Liao L, Du L. miR-144-3p inhibits tumor cell growth and invasion in oral squamous cell carcinoma through the downregulation of the oncogenic gene, EZH2[J]. Int J Mol Med, 2020, 46(2): 828-838. DOI: 10.3892/ijmm.2020.4638. |
[5] | 何翘楚. circ_UBE2D2/miR-144-3p调控宫颈癌SiHa细胞增殖、凋亡、迁移及侵袭的机制研究[J]. 中国细胞生物学学报, 2023, 45(5): 697-704. DOI:10.11844/cjcb.2023.05.0001. |
[6] |
Nishi M, Shimada M, Yoshikawa K, et al. Impact of CKLF-like MARVEL transmembrane domain containing 6 (CMTM6) expression in gastric cancer[J]. J Med Invest, 2021, 68(3.4): 362-367. DOI: 10.2152/jmi.68.362.
pmid: 34759159 |
[7] | 中华人民共和国国家卫生和计划生育委员会. 宫颈癌及癌前病变规范化诊疗指南(试行)[J]. 中国医学前沿杂志(电子版), 2013, 5(8): 40-49. DOI: 10.3969/j.issn.1674-7372.2013.08.010. |
[8] | 鲁琦, 张震宇. 国际妇产科联盟2018年版子宫颈癌分期标准的解读[J]. 中华妇产科杂志, 2019, 54(10): 718-720. DOI: 10. 3760/cma.j.issn.0529-567x.2019.10.014. |
[9] | 员小春, 刘梅梅. 经阴道实时超声弹性成像对正常宫颈、宫颈癌前病变和宫颈癌的诊断价值[J]. 实用癌症杂志, 2017, 32(5): 799-801. DOI: 10.3969/j.issn.1001-5930.2017.05.032. |
[10] | Omenai SA, Ajani MA, Okolo CA. Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients[J]. PLoS One, 2022, 17(2): e0263615. DOI: 10.1371/journal.pone.0263615. |
[11] | 袁晨阳, 周菊英. 宫颈癌预后因素的研究进展[J]. 国际肿瘤学杂志, 2022, 49(5): 307-313. DOI: 10.3760/cma.j.cn371439-20220303-00057. |
[12] | 张韶凯, 罗喜平, 李志芳, 等. 人乳头瘤病毒分型检测在宫颈癌前病变和宫颈癌筛查中的应用价值[J]. 中华肿瘤杂志, 2020, 42(3): 252-256. DOI: 10.3760/cma.j.cn112152-20190603-00346. |
[13] | Săsăran V, Turdean S, Mărginean C, et al. Transvaginal ultrasound combined with Strain-Ratio elastography for the concomitant diagnosis of uterine fibroids and adenomyosis: a pilot study[J]. J Clin Med, 2022, 11(13): 3757. DOI: 10.3390/jcm11133757. |
[14] | Zhang HP, Wu JJ, Zhang WY, et al. Evaluation of the stiffness of normal cervix and its change with different factors using transvaginal two-dimensional shear wave elastography under strict quality control[J]. BMC Med Imaging, 2023, 23(1): 65. DOI: 10.1186/s12880-023-01020-7. |
[15] | 施燕芸, 吴秀花, 李晓琴, 等. 经阴道常规超声联合实时超声弹性成像评估宫颈癌同步放化疗疗效[J]. 中国医学影像技术, 2021, 37(7): 1039-1043. DOI: 10.13929/j.issn.1003-3289.2021.07.018. |
[16] | 胡健, 王瑜, 刘明春. 经阴道实时超声弹性成像技术在宫颈癌及癌前病变鉴别诊断中的应用价值探讨[J]. 实用医院临床杂志, 2021, 18(1): 89-92. DOI: 10.3969/j.issn.1672-6170.2021.01.025. |
[17] | Wu P, Li CX, Ye DM, et al. Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375/409-3P/515-5p-SLC7A11 axis[J]. Aging (Albany NY), 2021, 13(3): 4663-4673. DOI: 10.18632/aging.202518. |
[18] | Li BT, Zhang SP, Shen H, et al. MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3[J]. Biochem Biophys Res Commun, 2017, 484(2): 241-247. DOI: 10.1016/j.bbrc.2017.01.084. |
[19] | 胡滨, 袁金金. circPUM1靶向调控miR-144-3p对宫颈癌细胞放射抵抗的影响[J]. 浙江大学学报(医学版), 2022, 51(2): 215-224. DOI: 10.3724/zdxbyxb-2022-0021. |
[20] |
Wu J, Zhao Y, Li F, et al. MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer[J]. J Physiol Biochem, 2019, 75(2): 143-152. DOI: 10.1007/s13105-019-00681-9.
pmid: 31016619 |
[21] |
Wu X, Lan X, Hu W, et al. CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer[J]. Cancer Immunol Immunother, 2021, 70(11): 3235-3248. DOI: 10.1007/s00262-021-02931-6.
pmid: 33818637 |
[22] |
Zheng Y, Wang C, Song A, et al. CMTM6 promotes cell proliferation and invasion in oral squamous cell carcinoma by interacting with NRP1[J]. Am J Cancer Res, 2020, 10(6): 1691-1709.
pmid: 32642284 |
[23] | Huang XT, Liu W, Liu CS, et al. CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study[J]. Front Mol Biosci, 2022, 9: 983410. DOI: 10.3389/fmolb.2022.983410. |
[1] | Peng Dan, Lyu Lu, Sun Pengfei. Research progress of radiomics in cervical cancer [J]. Journal of International Oncology, 2024, 51(8): 532-537. |
[2] | Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291. |
[3] | Gong Yan, Chen Honglei. Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer [J]. Journal of International Oncology, 2024, 51(3): 186-190. |
[4] | Zhang Lu, Jiang Hua, Lin Zhou, Ma Chenying, Xu Xiaoting, Wang Lili, Zhou Juying. Analysis of curative effect and prognosis of immune checkpoint inhibitor in the treatment of recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2023, 50(8): 475-483. |
[5] | Lyu Lu, Sun Pengfei. Gut flora and cervical cancer [J]. Journal of International Oncology, 2023, 50(6): 373-376. |
[6] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin. lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway [J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[7] | Ma Xueyan, Lu Lili, Sun Pengfei. Advances in the immune microenvironment in cervical cancer [J]. Journal of International Oncology, 2023, 50(1): 47-50. |
[8] | Zhang Lu, Zhou Juying, Ma Chenying, Lin Zhou. Advances in immunotherapy for recurrent and metastatic cervical cancer [J]. Journal of International Oncology, 2022, 49(9): 517-520. |
[9] | Shi Yingxia, Hu Lijun, Yu Jingping. Application of immune checkpoint inhibitors in the treatment of recurrent or metastatic cervical cancer [J]. Journal of International Oncology, 2022, 49(9): 568-571. |
[10] | Peng Chen, Xie Yintong, Zhang Xin, Xie Peng. Research progress of maintenance therapy for cervical cancer [J]. Journal of International Oncology, 2022, 49(7): 430-435. |
[11] | Yuan Chenyang, Zhou Juying. Research progress on prognostic factors of cervical cancer [J]. Journal of International Oncology, 2022, 49(5): 307-313. |
[12] | Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing. MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2 [J]. Journal of International Oncology, 2022, 49(4): 193-198. |
[13] | Jin Jiahui, Chen Cunhai, Ma Xuezhen. Effects of radiation-associated miRNA in radiotherapy for breast cancer [J]. Journal of International Oncology, 2022, 49(12): 735-738. |
[14] | Wang Yue, Wu Qiong, Xu Yuan, Gong Wei, Xu Xiaoting. Screening and treatment progression of elderly cervical cancer [J]. Journal of International Oncology, 2022, 49(12): 754-758. |
[15] | Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei. Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer [J]. Journal of International Oncology, 2022, 49(11): 681-686. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||